Source: International Congress 2018 – ILDs: From bench to bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Wijsenbeek (Rotterdam, Netherlands), F. Floricel (Mechelen, Belgium), J. Thonnard (Mechelen, Belgium), A. Fieuw (Mechelen, Belgium), P. Ford (Mechelen, Belgium), E. Santermans (Mechelen, Belgium), C. Vandenrijn (Mechelen, Belgium), T. Maher (London, United Kingdom). Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries. 263

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - COPD patient´s adherence to pulmonary rehabilitation programs: scoping review Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD Year: 2021 Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians. Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Late Breaking Abstract - Development of a self-management package for pulmonary fibrosis: an international Delphi study Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Late Breaking Abstract: Non-steroid agents for idiopathic pulmonary fibrosis: A systematic review Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Late Breaking Abstract - Real world patient-reported outcomes in asthma across six European countries: the NEWTON study Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Late Breaking Abstract - Early ICU physiotherapy on SARS-CoV-2 patients: A Spanish experience case series Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020 Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Late Breaking Abstract - Identification of obstructive lung disease in Austrian pharmacies - a multi-site, cross-sectional case finding study Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance? Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020 Year: 2020 Late Breaking Abstract - Silicosis in Spain: a 2016 point prevalence overview in employed workers Source: International Congress 2017 – Silicosis has not gone away Year: 2017 Late Breaking Abstract - Evaluating the feasibility, safety, and efficacy of senolytics in idiopathic pulmonary fibrosis Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Lessons from introducing DEKAs as a means of vitamin supplementation in paediatric Cystic Fibrosis patients. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Late Breaking Abstract - Day case medical thoracoscopy safety: tertiary centre review Source: International Congress 2018 – Pleural interventions Year: 2018 Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Late Breaking Abstract - Tocilizumab administration for the treatment of hospitalised patients with COVID-19: A systematic review and meta-analysis Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021 Epigenetics and pulmonary diseases in the horizon of precision medicine: a review Source: Eur Respir J, 57 (6) 2003406; 10.1183/13993003.03406-2020 Year: 2021 Late Breaking Abstract - Lung involvement is clue for recognizing severe dengue-A retrospective study Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020 Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - Self-management interventions for patients with COPD – a Cochrane review Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021